K
TH
Skip to content
Cover image for stem cells and psoriasis

Psoriasis: when the skin mirrors an immune problem

Not only a skin disease — joints and metabolism are involved

Quick answer

Psoriasis arises when immune signalling drives skin cells to divide far too fast, producing thick scaly plaques. A share of patients also develop arthritis, and metabolic risk runs higher than average. The cell therapy idea is systemic immune rebalancing rather than treating skin alone.

Key facts

Inflammatory axis
IL-17 / IL-23
Outcome score
PASI
Common comorbidity
Psoriatic arthritis
Triggers
Stress, smoking, alcohol

The IL-17 and IL-23 axis

The central inflammatory axis in psoriasis is IL-17 and IL-23, the target of modern biologics that work very well. Anyone who has not tried them should discuss that with a dermatologist before turning to investigational options.

Measuring with PASI

MSCs are studied here because they can dampen Th17 cells, the source of IL-17. Outcomes are scored with PASI, which grades plaque thickness, redness and scaling, giving a numeric before-and-after comparison.

Triggers you can control

Do not overlook the triggers you control: stress, smoking, alcohol, excess weight and throat infections. Managing them genuinely reduces flare frequency at almost no cost.

Frequently asked questions

  • Is psoriasis contagious?

    No — it is the patient's own immune process.

  • Is treatment lifelong?

    It typically relapses and remits, so the aim is control and fewer flares rather than permanent cessation.

  • What is Psoriasis: when the skin mirrors an immune problem?

    Psoriasis arises when immune signalling drives skin cells to divide far too fast, producing thick scaly plaques. A share of patients also develop arthritis, and metabolic risk runs higher than average. The cell therapy idea is systemic immune rebalancing rather than treating skin alone.

  • Psoriasis: when the skin mirrors an immune problem: what is the inflammatory axis?

    Inflammatory axis: IL-17 / IL-23

Medical cautions

5 points • reviewed 2026-08-28

Expand
  • This article is educational information only — not a diagnosis, prescription, or personal medical advice.
  • Outcomes vary by person, depending on age, underlying conditions, current medication, and the treating doctor's technique.
  • Consult a licensed physician and verify the clinic's licence before deciding on any treatment.
  • Some treatments (certain stem cell therapies in particular) are regulated differently by country — check Thai and Korean rules before travelling.
  • Prices, packages, and service details can change — confirm directly with the provider before paying.

Reviewed and last updated: 2026-08-28

References and sources

10 sources • every claim is traceable

Expand
  1. 1. EHL Bio — company introduction

    https://www.ehlbio.co.kr/company/about/

  2. 2. EHL Bio — company history

    https://www.ehlbio.co.kr/company/history/

  3. 3. EHL Bio — GMP centre

    https://www.ehlbio.co.kr/rd/gmp/

  4. 4. EHL Bio — stem cell therapeutics pipeline

    https://www.ehlbio.co.kr/rd/institute/

  5. 5. EHL Bio — patents and research papers

    https://www.ehlbio.co.kr/rd/patent/

  6. 6. EHL Bio — EHL-STEM conditioned media

    https://www.ehlbio.co.kr/conditioned/

  7. 7. EHL Bio — immune cells

    https://www.ehlbio.co.kr/immune_cell/

  8. 8. EHL Bio — target diseases

    https://www.ehlbio.co.kr/cure/index/

  9. 9. EHL Bio — locations and contact

    https://www.ehlbio.co.kr/company/contact/

  10. 10. Original article on khunkim.com (pre-migration)

    https://www.ehlbio.co.kr

Browse the full reference library →

Share this page

Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.

Back to categories

Related articles

See all articles

Read next in stem cells

Related topics: Joints & immunity

Related

Related articles

See all in this category